BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22564472)

  • 1. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.
    Lee SY; Song KH; Koo I; Lee KH; Suh KS; Kim BY
    Genomics; 2012 Jun; 99(6):347-54. PubMed ID: 22564472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
    Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
    van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
    Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
    Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
    Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
    Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resampling based on geographic patterns of hepatitis virus infection reveals a common gene signature for early intrahepatic recurrence of hepatocellular carcinoma.
    Uchimura S; Iizuka N; Tamesa T; Miyamoto T; Hamamoto Y; Oka M
    Anticancer Res; 2007; 27(5A):3323-30. PubMed ID: 17970077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N; Oka M; Yamada-Okabe H; Hamada K; Nakayama H; Mori N; Tamesa T; Okada T; Takemoto N; Matoba K; Takashima M; Sakamoto K; Tangoku A; Miyamoto T; Uchimura S; Hamamoto Y
    Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
    Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
    Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
    Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
    Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
    Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
    De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
    J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
    Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
    Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.